1. Butman JA, Linehan WM, Lonser RR. Neurologic manifestations of von Hippel-Lindau disease. JAMA 2008;300:1334–1342. PMID:
18799446.
2. Catapano D, Muscarella LA, Guarnieri V, Zelante L, D'Angelo VA, D'Agruma L. Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management. Neurosurgery 2005;56:1215–1221. PMID:
15918937.
3. Lonser RR, Weil RJ, Wanebo JE, DeVroom HL, Oldfield EH. Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 2003;98:106–116. PMID:
12546358.
4. Klekamp J. Treatment of intramedullary tumors: analysis of surgical morbidity and long-term results. J Neurosurg Spine 2013;19:12–26. PMID:
23682807.
5. Browne TR, Adams RD, Roberson GH. Hemangioblastoma of the spinal cord: review and report of five cases. Arch Neurol 1976;33:435–441. PMID:
945725.
6. Neumann HP, Eggert HR, Weigel K, Friedburg H, Wiestler OD, Schollmeyer P. Hemangioblastomas of the central nervous system: a 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg 1989;70:24–30. PMID:
2909683.
7. Neumann HP, Wiestler OD. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet 1991;337:1052–1054. PMID:
1673491.
8. Neumann HP, Eggert HR, Scheremet R, et al. Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 1992;55:898–901. PMID:
1431953.
9. Leung RS, Biswas SV, Duncan M, Rankin S. Imaging features of von Hippel-Lindau disease. Radiographics 2008;28:65–79. PMID:
18203931.
10. Gupte S. Recent advances in pediatrics, special volume, 18: pediatric neurology. New Delhi: Jaypee Bros. Medical Publishers; 2008.
11. Brauch H, Kishida T, Glavac D, et al. Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Hum Genet 1995;95:551–556. PMID:
7759077.
12. Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M, Kaelin WG Jr. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Hum Mol Genet 2001;10:1019–1027. PMID:
11331612.
13. McNeill A, Rattenberry E, Barber R, Killick P, MacDonald F, Maher ER. Genotype-phenotype correlations in VHL exon deletions. Am J Med Genet A 2009;149:2147–2151.
14. Na JH, Kim HS, Eoh W, Kim JH, Kim JS, Kim ES. Spinal cord hemangioblastoma: diagnosis and clinical outcome after surgical treatment. J Korean Neurosurg Soc 2007;42:436–440. PMID:
19096585.
15. Richard S, David P, Marsot-Dupuch K, Giraud S, Beroud C, Resche F. Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease. Neurosurg Rev 2000;23:1–22. PMID:
10809480.
16. Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery 2001;48:55–62. PMID:
11152361.
17. Pluta RM, Wait SD, Butman JA, et al. Sacral hemangioblastoma in a patient with von Hippel-Lindau disease: case report and review of the literature. Neurosurg Focus 2003;15:E11.
18. Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B. von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 1995;194:629–642. PMID:
7862955.
19. Glasker S, Berlis A, Pagenstecher A, Vougioukas VI, Van Velthoven V. Characterization of hemangioblastomas of spinal nerves. Neurosurgery 2005;56:503–509. PMID:
15730575.
20. Wanebo JE, Lonser RR, Glenn GM, Oldfield EH. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 2003;98:82–94. PMID:
12546356.
21. Xu QW, Bao WM, Mao RL, Yang GY. Magnetic resonance imaging and microsurgical treatment of intramedullary hemangioblastoma of the spinal cord. Neurosurgery 1994;35:671–675. PMID:
7808610.
22. Malis LI. Atraumatic bloodless removal of intramedullary hemangioblastomas of the spinal cord. J Neurosurg 2002;97:1–6.
23. Eskridge JM, McAuliffe W, Harris B, Kim DK, Scott J, Winn HR. Preoperative endovascular embolization of craniospinal hemangioblastomas. AJNR Am J Neuroradiol 1996;17:525–531. PMID:
8881249.
24. Tampieri D, Leblanc R, TerBrugge K. Preoperative embolization of brain and spinal hemangioblastomas. Neurosurgery 1993;33:502–505. PMID:
8413884.
25. Roonprapunt C, Silvera VM, Setton A, Freed D, Epstein FJ, Jallo GI. Surgical management of isolated hemangioblastomas of the spinal cord. Neurosurgery 2001;49:321–327. PMID:
11504107.
26. von Eiselsberg AF, Ranzi E. Ueber die chirurgische behandlung der hirn-und ruckenmarkstumoren. Arch Klin Chir 1913;102:309–468.
27. Cushing H, Bailey P. Tumours arising from the blood vessels of the brain: angiomatous malformations and hemangioblastomas. Springfield: Charles C Thomas; 1928.
28. Van Velthoven V, Reinacher PC, Klisch J, Neumann HPH, Glasker S. Treatment of intramedullary hemangioblastomas, with special attention to von hippel-lindau disease. Neurosurgery 2003;53:1306–1314. PMID:
14633297.
29. Miyagami M, Katayama Y. Long-term prognosis of hemangioblastomas of the central nervous system: clinical and immunohistochemical study in relation to recurrence. Brain Tumor Pathol 2004;21:75–82. PMID:
15700837.
30. Niemela M, Lemeta S, Summanen P, et al. Long-term prognosis of haemangioblastoma of the CNS: impact of von Hippel-Lindau disease. Acta Neurochir (Wien) 1999;141:1147–1156. PMID:
10592114.